OSR Health, Inc. 8K

OSR Health, Inc. received a Nasdaq Staff Delisting Determination for failing to meet the minimum bid price requirement and will appeal to a Nasdaq Hearings Panel, but its OSRH common stock and OSRHW warrants are scheduled to be suspended from trading on August 26, 2026.

On August 19, 2026, OSR Health, Inc. announced that it received a Nasdaq Staff Delisting Determination notifying the company that its common stock and warrants are subject to delisting from The Nasdaq Capital Market due to failure to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) within the allotted compliance periods; the company intends to request a hearing before a Nasdaq Independent Hearings Panel to appeal the determination, while warning investors that because it is in its second 180‑day compliance period, trading in its common stock (OSRH) and warrants (OSRHW) will be suspended at the opening of business on August 26, 2026, and there can be no assurance that continued listing or reinstatement will be granted.

Filing Facts

CIK

1840425

Ticker

-

Form

8K

Source Type

sec

Accession

0001213900-26-091756

Alert Tier

8